The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemiaPhilip O. Saunders, Linda J. Bendall|Haematologica|2010Cited by 60